Stories
PrivateLast Round
Series B
Aug 21, 2024
Est. Valuation
$2.25B
Total Funding Raised
$134.3M
Momentum Score
25 /100
Company Overview
Stories is a real estate technology company that provides co-working spaces and practice rooms for therapists, psychologists, and coaches in the Netherlands.
Sector
Real Estate & PropTech
Verticals
Mental Health, Co-working Spaces, PropTech Services, Tenant Experience
Business Model
B2B2C
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Stories Comps
Public and private peers based on sector, stage, and business model.
Stories Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 21, 2024 | ||||
| Series A | Sep 6, 2023 | ||||
| Seed | May 17, 2023 |
Key People
Founding team and executive leadership
Stories Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Polychain Capital | Series B |
| dao5 | Seed, Series A |
| 11:11 Media | Series A |
| Foresight Ventures | Series A |
| Samsung Next TLV | Series B, Series A |
| Two Small Fish Ventures | Seed, Series A |
| Samsung NEXT Fund | Seed |
Stories Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Stories's valuation, stock price, and market status.